Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
GSKCONS
GSKCONS

GlaxoSmithKline Consumer Healthcare Ltd

NSE: GSKCONS
BSE: 500676
Sector:
Industry Group:
Industry:
10,732.60+0.0 (+0.00%)
20 Aug, 12:00 AM

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap
-
P/E (TTM)
-
P/B
-
P/S (TTM)
-
EV/EBITDA
-
CAPE (5Y)
54.29
ROE (TTM)
-
ROCE (TTM)
-
ROA (TTM)
-
Avg 3Y ROE
-
Earnings 3Y CAGR
-
Sales 3Y CAGR
-
Sales 5Y CAGR
-
Debt/Equity
-
Consensus TP
-
Strong Buy %
-
Promoter Holding
-
Pledged %
-

Share Price

Track GlaxoSmithKline Consumer Healthcare Ltd's current share price, historical price chart, 52-week high/low, and performance across different time periods.

Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Stock Analysis

Fundamental analysis overview of GlaxoSmithKline Consumer Healthcare Ltd covering key investment insights, growth drivers, risk factors, and potential red flags.

Views
Red Flags
Positive
Not enough talking points with positive stance
Negative
Stock is fairly expensive with negative EPS on a trailing 12-month basis

Earnings yield of nan% indicates that the stock is very expensive and has a negative EPS on a trailing 12-month basis

What is Earnings yield (E/P)?

Low dividend yield

The company has a low dividend yield of 0.98%

What is Dividend yield?

Neutral
Not enough talking points with neutral stance
No red flags found!
No significant red flags found in the stock.

Financial Snapshot

See detailed analysis

Multi-year trends for GlaxoSmithKline Consumer Healthcare Ltd covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY
Not enough data
Profit After Tax FY
Not enough data
ROE FY
Not enough data
EBITDA FY
Not enough data

GlaxoSmithKline Consumer Healthcare Ltd Shareholding Pattern

Quarterly breakdown of GlaxoSmithKline Consumer Healthcare Ltd ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019
Total Promoter
72.46
72.46
72.46
72.46
72.46
72.46
72.46
72.46
72.46
72.46
72.46
72.46
72.46
72.46
72.46
72.46
72.46
72.46
72.46
72.46
Indian Promoter
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Foreign Promoter
72.46
72.46
72.46
72.46
72.46
72.46
72.46
72.46
72.46
72.46
72.46
72.46
72.46
72.46
72.46
72.46
72.46
72.46
72.46
72.46
Institutions
12.95
12.81
12.57
12.65
12.72
12.44
12.99
12.77
12.76
12.79
12.86
12.79
12.74
12.39
12.29
12.01
11.49
11.12
11.29
11.14
Mutual Funds / UTI
1.57
1.70
1.63
1.71
2.69
3.21
3.37
5.42
5.87
5.73
5.77
5.57
5.18
5.41
5.36
4.42
4.30
4.02
4.03
3.68
FI/Bank/Insurance
0.77
0.73
0.70
0.67
0.99
1.20
1.28
1.86
2.52
2.91
3.14
3.12
3.02
3.02
2.92
2.90
2.91
2.91
2.89
2.88
Govt
-
-
-
-
0.00
0.00
0.00
0.00
-
-
-
-
-
-
-
-
-
-
-
-
FII
10.60
10.37
10.23
10.28
9.04
8.03
8.34
5.49
4.37
4.15
3.95
4.10
4.54
3.96
4.00
4.68
4.27
4.20
4.37
4.58
Other Institutions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.02
0.01
0.01
0.00
0.00
0.00
0.00
0.00
Non-Institution
14.60
14.73
14.98
14.89
14.83
15.10
14.56
14.77
14.78
14.75
14.68
14.76
14.80
15.15
15.26
15.54
16.05
16.42
16.26
16.40
Bodies Corporate
1.65
1.81
2.01
-
1.72
-
1.48
1.53
1.53
1.63
1.74
1.99
1.97
2.32
2.38
2.54
2.79
3.24
1.20
1.37
Others (incl. Retail)
No. of shareholders
12.95
26,311
12.92
27,143
12.97
29,028
14.89
31,351
13.11
32,169
15.10
34,466
13.08
34,274
13.24
38,376
13.25
40,784
13.12
40,105
12.94
39,818
12.77
38,537
12.83
44,601
12.83
46,610
12.88
50,273
13.00
52,601
13.26
53,642
13.18
53,407
15.06
53,170
15.03
52,824

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in GlaxoSmithKline Consumer Healthcare Ltd shares as reported to NSE and BSE.

No bulk, block or insider trade data available.

No corporate action data available.

Company Profile

Overview of GlaxoSmithKline Consumer Healthcare Ltd covering business description, industry classification, key management, financial ratios, and listed exchange details.

Key personnel
Mr. Ronojit Biswas
Whole Time Director, Chief Financial Officer
Ms. Sukanya Choudhury
Executive Vice President, Regulatory Affairs
Mr. Carson Dalton
Executive Vice President, Communications, Government Affairs
Mr. Rishikesh S. Jaiwant
Executive Vice President, Supply Chain Operations
Ms. Shalini Menon
Executive Vice President, Medical Affairs
Mr. Amit Pandey
Executive Vice President, Legal
Mr. Vishwanath Swarup
Executive Vice President, General Medicines
Mr. Harsh Trehan
Executive Vice President, Human Resources
View all
Incorporated on
30 Oct 1958
Last Annual
31 Mar 2019
Last Interim
31 Dec 2019
No. of Employees
3,844
IPO date
-
Free Float
-
Phone no.
+911244336500
Address
24th Floor, One Horizon Center, Golf Course Road, DLF Phase - V Gurgaon, GURGAON, 122002, India

Frequently Asked Questions

What is the current share price of GlaxoSmithKline Consumer Healthcare Ltd?
The current share price of GlaxoSmithKline Consumer Healthcare Ltd is ₹ 10,732.60 as of 20 Aug 2020.
What is the market capitalisation of GlaxoSmithKline Consumer Healthcare Ltd?
The market capitalisation of GlaxoSmithKline Consumer Healthcare Ltd stands at -.
What is the PE ratio of GlaxoSmithKline Consumer Healthcare Ltd?
The Price-to-Earnings (PE) ratio of GlaxoSmithKline Consumer Healthcare Ltd is - as of the latest trailing twelve months data.
What is the ROE and ROCE of GlaxoSmithKline Consumer Healthcare Ltd?
GlaxoSmithKline Consumer Healthcare Ltd has a Return on Equity (ROE) of - and a Return on Capital Employed (ROCE) of - as per the latest financial reports.
What is the 52-week high and low of GlaxoSmithKline Consumer Healthcare Ltd?
The 52-week high of GlaxoSmithKline Consumer Healthcare Ltd is - and the 52-week low is -.
What is the dividend yield of GlaxoSmithKline Consumer Healthcare Ltd?
The dividend yield of GlaxoSmithKline Consumer Healthcare Ltd is 0.98% based on the current market price.
What is the FII and DII holding in GlaxoSmithKline Consumer Healthcare Ltd?
Foreign Institutional Investors (FII) hold -, Domestic Institutional Investors (DII) hold - of GlaxoSmithKline Consumer Healthcare Ltd shares.
What sector does GlaxoSmithKline Consumer Healthcare Ltd belong to?
GlaxoSmithKline Consumer Healthcare Ltd operates in the - sector.
What is the beta of GlaxoSmithKline Consumer Healthcare Ltd?
The beta of GlaxoSmithKline Consumer Healthcare Ltd is 0.57, indicating its price volatility relative to the broader market. Over the past 1 year, GlaxoSmithKline Consumer Healthcare Ltd has delivered an absolute return of 34.71%.
What is the RSI of GlaxoSmithKline Consumer Healthcare Ltd?
The 14-day Relative Strength Index (RSI) of GlaxoSmithKline Consumer Healthcare Ltd is 62.66, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.